Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024
September 03, 2024 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
BioConnection appoints Dr. Gary M. Phillips as new Chairman of its Supervisory Board
August 30, 2024 04:43 ET
|
BioConnection
OSS, The Netherlands – 30 August 2024, BioConnection, a leading Dutch contract development and manufacturing organization (CDMO) in the pharmaceutical industry, today announced the appointment of Dr....
Lifecore Biomedical Announces Chief Financial Officer Transition
August 29, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Contract Development & Manufacturing Organization Market Report 2024: Asia Pacific is the Fastest Growing Market for CDMOs
August 28, 2024 04:16 ET
|
Research and Markets
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "Contract Development & Manufacturing Organization (CDMO) Market: Insights & Forecast (2024-2028)" report has been added to ...
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update
August 26, 2024 17:23 ET
|
Lifecore Biomedical, Inc.
-- Recorded Revenues of $128.3 million for Fiscal 2024; Year-Over-Year Increase of 24.2% ---- High Value Pipeline Continues to Advance Toward Commercialization ---- State-of-the-Art Technology...
U.S. Small Molecule Innovator API CDMO Market Analysis Report 2024-2030: Increasing Demand for Small Molecule Drugs and Outsourcing Among Pharmaceutical Companies
August 06, 2024 11:29 ET
|
Research and Markets
Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "U.S. Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type (Preclinical, Clinical, Commercial), Customer...
Global Pharmaceutical Contract Manufacturing Business Research Report 2024: Market to Reach $159.8 Billion by 2030 - Exploring & Exploiting New Technologies for Rich Dividends
July 31, 2024 04:17 ET
|
Research and Markets
Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
Integer Holdings Corporation Reports Second Quarter 2024 Results
July 25, 2024 08:00 ET
|
Integer Holdings Corporation
~ Continued strong performance with 2Q24 financial results ~~ Raising full year 2024 profit outlook ~ PLANO, Texas, July 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR)...
Global Nutraceuticals CDMO Industry Research 2024: Size, Share, Trends, Opportunity, and Competitive Landscape, 2019-2029F
July 22, 2024 04:46 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Nutraceuticals CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Crossject franchit une nouvelle étape clé dans la fabrication de ZEPIZURE®
July 18, 2024 01:30 ET
|
CROSSJECT
Fabrication réussie d’un autre Lot Règlementaire de ZEPIZURE® sur le nouveau site de fabricationUne étape importante qui complète les résultats satisfaisants obtenus avec les lots précédents dans le...